dr. reddy's labs glp-1 receptor agonist weight management diabetes treatments Frontiers Current Insights, Advantages and Challenges
Description
The Canadian Anesthesiologists Society (CAS), in its 2023 safety alert, recommended that patients receiving semaglutide be considered non-fasting even after adequate fasting [6]
[PMID 41837981] DRUG INTERACTIONS NOTE: The drug interactions presented here are NOT all-inclusive
Prior cases involved attention-deficit/hyperactivity disorder medications and other controlled substances prescribed by telehealth providers, she said
Reassure based on current evidence (no excess malformation risk)
Saxenda is not safe to use during pregnancy
Key Point: Which Medications Are GLP-1 Agonists
